Michigan 悔婚拒返彩礼被拘 意大利居民楼倒塌

August 22,2014 : Company Profiles and Conferences presents a Company Report on "Esperion Therapeutics, Inc. (ESPR) – Pharmaceuticals & Healthcare", he companys second generation compounds impacts lipid and carbohydrate metabolism and inflammation Summary Esperion Therapeutics, Inc. (Esperion) is a biotechnology company. The company develops and commercializes oral, small molecule therapies for the treatment of patients with low-density lipoprotein cholesterol and other cardiometabolic risk factors. Esperions products include ETC-1002, ESP41091, 4WF, and HDL Mimetics. Its ETC-1002 is an oral drug for patients who have/are at risk for developing, cardiovascular and metabolic diseases. The companys second generation compounds impacts lipid and carbohydrate metabolism and inflammation; and HDL mimetic therapies are designed to rapidly eliminate cholesterol and other lipids from the arterial wall and related tissues. The company operates as a subsidiary of Pfizer Inc. Esperion is headquartered in Plymouth, Michigan, the US. Esperion Therapeutics, Inc. (ESPR) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research. Scope – Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. – Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. – Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. – Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. – Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector. – Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios. – Business Description – A brief description of the company’s operations. For more information kindly visit: Related link: About Company Profiles and Conferences Search thousands of company profiles, SWOT analysis reports and company financials. Search by industry sector, or simply search all company profiles by company name. companyprofilesandconferences.com contains one of the world’s largest collections of company insight and company profiles from leading global market report publishers and analysts. Global brands rely on companyprofilesandconferences.com for their strategic company insight and company profile needs. Contact us at: Company Profiles And Conferences Mob +919223375060 / 919223767111 Fax : +91 22 27810778 E-mail : [email protected] Website : panyprofilesandconferences.com 相关的主题文章: